SPI Digital Health: Philips Gets Latest Vote of Confidence with $2.8B Deal
Published: September 28, 2023
Last month’s news that the Italian Agnelli-backed investment firm Exor had paid €2.6B ($2.8B) for a 15% stake in Philips was, in some respects, hardly surprising. Far from being a hopeful punt, Exor’s move was steeped in ambition and pragmatism, and with an eye for a good deal.
It is not entirely without risk, of course, but the potential in the deal is quite clear. On one side of the equation, a conglomerate that has had a challenging last three years, but appears to be emerging with refocused priorities. And on the other side of the equation, an investment house that has an appetite for healthcare, with minority stakes in healthcare providers in France and Italy.